Analyst Reco. Novo Nordisk AS CINNOBER BOAT

Equities

Delayed CINNOBER BOAT Other stock markets			5-day change	1st Jan Change
- ^DKK	-.--%		-.--%	-.--%

07-02	Tesla, megacaps drive S&P 500, Nasdaq higher; rates outlook in focus	RE
07-02	Novo Nordisk, Eli Lilly Charging 'Unconscionably' High Prices, Biden, Sanders Say	MT

Novo Nordisk, Eli Lilly Charging 'Unconscionably' High Prices, Biden, Sanders Say	07-02	MT
Biden says Novo Nordisk must cut prices of diabetes, weight loss drugs	07-02	RE
Novo Nordisk, Eli Lilly Charging 'Unconscionably' High Prices, Biden, Sanders Say in USA Today Op-Ed	07-02	MT
NOVO NORDISK : Jefferies reiterates its Sell rating	07-02	ZD
NOVO NORDISK : UBS gives a Neutral rating	06-28	ZD
NOVO NORDISK : JP Morgan gives a Buy rating	06-27	ZD
NOVO NORDISK : Goldman Sachs reiterates its Buy rating	06-27	ZD
AlphaValue/Baader Europe Downgrades Novo Nordisk to Add from Buy, Raises PT	06-26	MT
NOVO NORDISK : Deutsche Bank remains its Buy rating	06-25	ZD
NOVO NORDISK : Jefferies reiterates its Sell rating	06-24	ZD
NOVO NORDISK : Gets a Buy rating from JP Morgan	06-24	ZD
India's Biocon seeks partner to test generic Wegovy, Ozempic in China	06-20	RE
NOVO NORDISK : Deutsche Bank remains its Buy rating	06-20	ZD
NOVO NORDISK : Deutsche Bank reiterates its Buy rating	06-14	ZD
Sector Update: Health Care	06-11	MT
Senate Committee to Vote June 18 to Subpoena Novo Nordisk President Doug Langa	06-11	MT
Argus Research Raises Novo Nordisk Price Target to $160 From $125, Maintains Buy Rating	06-10	MT
NOVO NORDISK : Buy rating by Goldman Sachs	05-30	ZD
NOVO NORDISK : Deutsche Bank reaffirms its Buy rating	05-28	ZD
NOVO NORDISK : JP Morgan reiterates its Buy rating	05-24	ZD